KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Finished Goods (2016 - 2026)

CareDx's Finished Goods history spans 14 years, with the latest figure at $11.2 million for Q1 2026.

  • On a quarterly basis, Finished Goods rose 152.76% to $11.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.2 million, a 152.76% increase, with the full-year FY2025 number at $9.8 million, up 103.44% from a year prior.
  • Finished Goods hit $11.2 million in Q1 2026 for CareDx, up from $9.8 million in the prior quarter.
  • Over the last five years, Finished Goods for CDNA hit a ceiling of $11.2 million in Q1 2026 and a floor of $3.0 million in Q4 2022.
  • Historically, Finished Goods has averaged $5.3 million across 5 years, with a median of $4.4 million in 2024.
  • Biggest five-year swings in Finished Goods: fell 24.26% in 2022 and later soared 152.76% in 2026.
  • Tracing CDNA's Finished Goods over 5 years: stood at $3.0 million in 2022, then rose by 23.5% to $3.7 million in 2023, then skyrocketed by 31.74% to $4.8 million in 2024, then soared by 103.44% to $9.8 million in 2025, then rose by 13.95% to $11.2 million in 2026.
  • Business Quant data shows Finished Goods for CDNA at $11.2 million in Q1 2026, $9.8 million in Q4 2025, and $9.5 million in Q3 2025.